Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Leflunomide in systemic onset Juvenile idiopathic arthritis.

Jahan A, Dewan V, Yadav TP.

Indian Pediatr. 2012 Sep;49(9):750-2.

2.

Leflunomide or methotrexate for juvenile rheumatoid arthritis.

Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, Horneff G, Calvo I, Szer IS, Simpson K, Stewart JA, Strand V; Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group.

N Engl J Med. 2005 Apr 21;352(16):1655-66.

3.

Current treatment of juvenile rheumatoid arthritis.

Ilowite NT.

Pediatrics. 2002 Jan;109(1):109-15. Review.

PMID:
11773549
4.

Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.

Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V.

Arthritis Rheum. 2005 Feb;52(2):554-62.

5.

Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.

Behrens F, Koehm M, Burkhardt H.

Curr Opin Rheumatol. 2011 May;23(3):282-7. doi: 10.1097/BOR.0b013e328344fddb. Review.

PMID:
21427581
6.

Effectiveness of leflunomide in patients with juvenile idiopathic arthritis in clinical practice.

Foeldvari I, Wierk A.

J Rheumatol. 2010 Aug 1;37(8):1763-7. doi: 10.3899/jrheum.090874. Epub 2010 May 15.

PMID:
20472925
7.

What's new in the diagnosis and treatment of juvenile rheumatoid arthritis.

Sherry DD.

J Pediatr Orthop. 2000 Jul-Aug;20(4):419-20. Review. No abstract available.

PMID:
10912594
8.

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347. Epub 2011 May 28.

PMID:
21623000
9.

Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA).

Ohlsson V, Baildam E, Foster H, Jandial S, Pain C, Strike H, Ramanan AV.

Rheumatology (Oxford). 2008 Apr;47(4):555-6. doi: 10.1093/rheumatology/ken030. Epub 2008 Mar 5. No abstract available.

PMID:
18321945
10.

High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score.

Bulatović M, Heijstek MW, Verkaaik M, van Dijkhuizen EH, Armbrust W, Hoppenreijs EP, Kamphuis S, Kuis W, Egberts TC, Sinnema G, Rademaker CM, Wulffraat NM.

Arthritis Rheum. 2011 Jul;63(7):2007-13. doi: 10.1002/art.30367.

11.

[Personal experience with methotrexate in the treatment of idiopathic juvenile arthritis].

Tambić-Bukovac L, Malcić I, Prohić A.

Reumatizam. 2002;49(1):20-4. Croatian.

PMID:
12476749
12.

Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.

ten Cate R, van Suijlekom-Smit LW, Brinkman DM, Bekkering WP, Jansen-van Wijngaarden CJ, Vossen JM.

Rheumatology (Oxford). 2002 Feb;41(2):228-9. No abstract available.

PMID:
11886975
13.

Eosinophilia as a side-effect of methotrexate in patients with chronic arthritis.

Savolainen HA, Leirisalo-Repo M.

Clin Rheumatol. 2001;20(6):432-4.

PMID:
11771529
14.

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.

Arthritis Rheum. 2003 Apr;48(4):1093-101.

15.

[Drug treatment in juvenile chronic arthritis].

Goldenstein-Schainberg C, Yoshinari NH.

Rev Hosp Clin Fac Med Sao Paulo. 1997 Mar-Apr;52(2):90-5. Review. Portuguese.

PMID:
9435402
16.

Update on biologicals for treatment of juvenile idiopathic arthritis.

Horneff G.

Expert Opin Biol Ther. 2013 Mar;13(3):361-76. doi: 10.1517/14712598.2013.735657. Epub 2013 Jan 5. Review.

PMID:
23289865
17.

Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis.

Billiau AD, Loop M, Le PQ, Berthet F, Philippet P, Kasran A, Wouters CH.

Rheumatology (Oxford). 2010 Aug;49(8):1550-8. doi: 10.1093/rheumatology/keq123. Epub 2010 May 5.

PMID:
20444859
18.

Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.

Narváez J, Díaz-Torné C, Juanola X, Geli C, Llobet JM, Nolla JM, Díaz-López C.

Ann Rheum Dis. 2009 Apr;68(4):607-8. doi: 10.1136/ard.2008.092106. No abstract available.

PMID:
19286909
19.

[Medical treatment of juvenile idiopathic arthritis].

Horneff G, Augustin S.

Med Monatsschr Pharm. 2008 Sep;31(9):326-36; quiz 337-8. Review. German.

PMID:
18831464
20.

Nodulosis in systemic onset juvenile idiopathic arthritis: an uncommon event with spontaneous resolution.

Abdwani R, Scuccumarri R, Duffy K, Duffy CM.

Pediatr Dermatol. 2009 Sep-Oct;26(5):587-91. doi: 10.1111/j.1525-1470.2009.00990.x.

PMID:
19840317

Supplemental Content

Support Center